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 Abstract 
Inorganic nitrate was once considered an oxidation end-product of nitric oxide metabolism 
with little biological activity. However, recent studies have demonstrated that dietary nitrate 
can modulate mitochondrial function in man and is effective in reversing features of the 
metabolic syndrome in mice. Using a combined histological, metabolomics, and 
transcriptional and protein analysis approach we mechanistically define that nitrate not only 
increases the expression of thermogenic genes in brown-adipose tissue but also induces the 
expression of brown adipocyte-specific genes and proteins in white adipose tissue, 
substantially increasing oxygen consumption and fatty acid β-oxidation in adipocytes. Nitrate 
induces these phenotypic changes through a mechanism distinct from known physiological 
small molecule activators of browning, the recently identified nitrate-nitrite-nitric oxide 
pathway. The nitrate-induced browning effect was enhanced in hypoxia, a serious co-
morbidity affecting white adipose tissue in obese individuals, and corrected impaired brown 
adipocyte-specific gene expression in white adipose tissue in a murine model of obesity. 
Since resulting beige/brite cells exhibit anti-obesity and anti-diabetic effects, nitrate may be 
an effective means of inducing the browning response in adipose tissue to treat the metabolic 
syndrome. 
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 The diffuse and complex nature of the metabolic syndrome integrates peripheral insulin 
resistance and visceral obesity with cardiovascular disease; making the discovery of 
underlying molecular mechanisms that unite the aspects of the metabolic syndrome both 
challenging and essential. The perturbation of nitric oxide (NO) synthesis and signaling has 
emerged as a potential modulator of both cardiovascular morbidity and metabolic dysfunction 
(1; 2). 
Until recently inorganic nitrate was considered a non-bioactive product of NO oxidation (3). 
However, a number of studies have identified nitrate treatment of humans and rodents as 
having effects similar to NO (4; 5). The discovery of anti-obesity effects of nitrate in rodents, 
including weight loss, a reduction of body fat, reversal of lipodystrophy and an improvement 
in glucose and insulin homeostasis, may highlight nitrate as having therapeutic potential for 
the treatment of the metabolic syndrome (6).  
Dietary nitrate increases the circulating concentration of cGMP in humans (7) and low 
nitrate/nitrite diets decrease steady-state concentrations of cGMP in a number of tissues (8). 
Recently, cGMP has been shown to regulate energy balance in white adipocytes (9). The 
development of a brown adipocyte-like phenotype in white adipocytes, a process known as 
“browning”, includes the induction of thermogenesis, the dissipation of chemical energy to 
produce heat (10; 11). Peroxisome proliferator activated receptor γ co-activator 1α (PGC-1α) 
activates key components of the thermogenic program in white adipocytes, including fatty 
acid oxidation, mitochondrial biogenesis, and increased oxygen consumption (12). The 
thermogenic process occurs through the activity and increased expression of several brown-
adipocyte specific genes including uncoupling protein 1 (UCP1), an inner mitochondrial 
membrane protein that uncouples the mitochondrial proton gradient (13). Cells expressing 
brown-adipocyte specific genes are interspersed within the white adipose tissue (WAT) of 
rodents and humans (so-called “beige” or “brite” cells) (14; 15)) and demonstrate anti-
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 diabetic and anti-obesity effects in rodent models (16-19). The recent discovery of a 
physiological small molecule activator of browning in WAT highlights metabolites as both 
potential mediators of the thermogenic response and therapeutics for the metabolic syndrome 
(20). 
In this study we investigate the effect of nitrate on WAT metabolism both in the classic 
experimental model of browning in vitro, the mouse primary adipocyte, and in vivo in mice 
and rats to establish whether this may, in part, explain the anti-obesity activity of nitrate. We 
demonstrate that nitrate increases the expression of brown-adipocyte specific genes and 
concordant proteins within white adipocytes to confer a brown-adipocyte like phenotype. 
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 Research Design and Methods 
Animal Experimentation. Male Wistar rats (6 weeks old) (269 ± 2 g; n = 24) (Charles 
River.) were weight matched and received either distilled water or water containing sodium 
nitrate (NaNO3) (0.35, 0.7, 1.4 mM; n = 6/group) (Ultra-pure, Sigma-Aldrich) ad libitum for 
18 days with food and water intake monitored.  Animals were housed in conventional cages 
at room temperature with a 12-hour/12-hour light/dark photoperiod. In the hypoxia study, 
male Wistar rats (6 weeks old) were weight matched and separated into two groups (n = 
10/group), housed in either normoxic or normobaric hypoxic environments (hypoxia 
chamber: 13% O2, with 20 air changes per hour). The rats in each group received either 
distilled water containing NaCl (n = 5, 0.7mM NaCl) or water containing NaNO3 (0.7 mM; n 
= 5) for 14 days. All other details are as above.   
 
Male p129 mice (6 weeks old) received either distilled water containing NaCl (0.7mM, 
Control, n = 7) or NaNO3 (0.7mM, n = 7) (Ultra-pure, Sigma-Aldrich) ad libitum for 15 days 
with food and water intake monitored.  
  
ob/ob mice (n = 10) and C57bl/6 wild type mice (n = 10) (9 weeks old, The Jackson 
Laboratory) received either distilled water containing NaCl (0.7mM, Control, n = 5) or 
NaNO3 (0.7mM, n = 5) (Ultra-pure, Sigma-Aldrich) ad libitum for 8 weeks with food and 
water intake monitored. Animals were housed in conventional cages at room temperature 
with a 12-hour/12-hour light/dark photoperiod.    
 
All animals had micro-nutrient levels normalized by a standardized quality controlled (SQC) 
diet (RM1 (E); 55% crude carbohydrate, 3% crude fat, 15% crude protein; Special Diets 
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 Services, UK) one week prior to study commencement. The nitrate content of this diet is 2 
mg/Kg and the nitrite content was undetectable below a threshold of 1 mg/Kg. 
 
All procedures were carried out in accordance with UK Home Office protocols by a personal 
license holder. 
 
Blood and Tissue Collection. Rats and mice were euthanized with sodium pentobarbital 
(200 mg/ml, Vétoquinol UK Ltd.). Blood was obtained by cardiac puncture, collected in N-
ethylmaleimide/EDTA (10 and 2.5 mM, respectively) containing tubes and immediately 
centrifuged to obtain plasma. WAT and interscapular brown adipose tissue (iBAT) were 
removed and flash frozen in liquid nitrogen. 
 
Histology. WAT was fixed for 24 hr in 10% formalin and washed for 1 hr in PBS before 
being set in wax. The tissue was then cut into 8 µm thick slices and stained with 
haematoxylin and eosin. 
 
Plasma Nitrate Measurements. Plasma nitrate was measured as described previously (21).   
 
Culture and Differentiation of Primary Adipocytes. Primary white adipose stromal 
vascular cells were fractionated from 6 – 10 week old C57BL6 male mice as previously 
described (22).  Stromal vascular cells were then cultured and differentiated into adipocytes 
according to published methods (22; 23).  During the 6 day differentiation, cells were 
cultured with either saline (control), 25 µM NaNO3, 50 µM NaNO3 or 500 µM NaNO3 (Ultra-
pure, Sigma-Aldrich) or, during the investigation of the effects of sodium nitrite (NaNO2), 
with saline (control), 50 µM NaNO2 or 500 µM NaNO2 (Ultra-pure, Sigma-Aldrich). The 
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 pharmacological inhibitor studies utilized 2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-
oxide (PTIO) (50 µM), NG-nitro-L-arginine methyl ester (L-NAME) (1 mM), 1H-[1,2,
4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (1 µM) (Sigma-Aldrich) and KT5823 (1 µM) 
(Santa Cruz Biotechnology). Cells were treated with PTIO, L-NAME, ODQ or KT5823 with 
and without 500 µM NaNO3. NaNO3 and inhibitors were added at day 1 of differentiation. In 
the hypoxia study, cells were isolated and differentiated as above. Hypoxic conditions were 
achieved using a New Brunswick Eppendorf Galaxy 14S incubator supplied with nitrogen 
and set to maintain a 2% O2 environment. 
 
siRNA Xanthine Oxidoreductase Knockdown. FlexiTube siRNA against XOR, AllStars 
negative control siRNA and HiPerFect Transfection Reagent were purchased from Qiagen. 
Transfection of primary adipocytes was carried out as per the manufacturer’s instructions (75 
ng siRNA, 3 µl transfection reagent per well,10 nM final siRNA concentration) on day 2 and 
4 of differentiation.  
 
Tissue and Primary Adipocyte Metabolite Extraction. Metabolites were extracted from 
WAT and primary adipocytes as previously described (24).  
 
13
C-palmitate Substrate Labeling Study. Palmitate was solubilized using a dialyzed 
albumin solution (24). At 6 days post-differentiation medium was removed from primary 
adipocytes and replaced with serum free media containing insulin 850 nM, triiodothyronin 1 
nM, and rosiglitazone 1 µM and 140 µM U-
13
C labeled palmitate (Cambridge Isotope 
Laboratories). After 2 days cells were collected and metabolites extracted as previously 
described. During the 8 days of the experiments duration, cells were cultured with either 
saline (control), 50 µM NaNO3 or 500 µM NaNO3. 
Page 7 of 52
For Peer Review Only
Diabetes
  
Gene Expression Analysis. Total RNA extraction from WAT, BAT, and adipocytes, cDNA 
conversion and quantitative RT-PCR was performed according to published protocols (20). 
All data were normalized to 18SrRNA (mouse WAT, BAT and adipocytes) or RLPL1 (rat 
WAT) and quantitative measures obtained using the ∆-∆-CT method.  
 
Protein Analysis. Analysis of UCP1 and PGC-1α was performed using ELISA as per the 
manufacturer’s instructions (UCP1 Kit SEF557Ra, PGC-1α Kit SEH337Ra, Cloud-Clone 
Corp. Houston, TX, USA). Immunoblotting for CPT1 was carried out as previously described 
(25).  
 
Citrate Synthase Assay. Citrate synthase was assayed according to Houle-Leroy et al.(26).  
 
White Adipocyte Respirometry. Oxygen consumption rates were measured in white 
adipocytes (250,000 cells) maintained in Krebs-Henseleit buffer at 37
○
C, using Clark-type 
oxygen electrodes (Strathkelvin Instruments, Strathkelvin, UK) as described previously (27).  
 
Gas Chromatography-Mass Spectrometry Analysis. Dried aqueous and organic phase 
samples were derivatized using the method described previously (24). Gas Chromatography-
Mass Spectrometry (GC-MS) and data analysis were performed according to published 
methods (24). 
 
13
C-labeled Substrate GC-MS Analysis. Analysis of organic and aqueous phases was 
carried out as described above and according to published methods (24).  
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 Liquid Chromatography-Mass Spectrometry Analysis of Intact Lipids. Liquid 
Chromatography-Mass Spectrometry (LC-MS) was performed on WAT using a Waters Q-
ToF Xevo mass spectrometer (Waters Corporation, Manchester, UK) operating with 
electrospray ionization in combination with an Acquity UPLC according to the method 
described by Roberts at al. (24).  LC-MS spectra and chromatograms were analyzed using the 
MarkerLynx Application MassLynx (version 4.1; Waters Corporation) using published 
protocols (24).   
 
LC-MS Analysis of cGMP. LC-MS analysis of cGMP was performed using a 4000 QTRAP 
triple quadrupole mass spectrometer (Applied Biosystems/Sciex), coupled to an Acquity 
UPLC (Waters Corporation, Manchester, UK) according to a previously described method 
(28). The multiple reaction monitoring parameters for cGMP were: Q1 = 346.13 m/z, Q3 = 
152.1 m/z, collision energy = 23, declustering potential = 41, collision cell exit potential = 10.   
 
Statistical Analyses. Error bars represent standard error of the mean. P-values were 
calculated by either one-way or two-way ANOVA as stated with a Dunnett’s post-hoc test 
when multiple comparisons where made solely to control and a Tukey’s post-hoc test when 
comparisons were made between all treatment groups.  
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 Results   
Nitrate Induces a Brown Adipocyte-like Phenotype in White Adipocytes In Vivo 
Rodents treated with dietary nitrate are protected against diabetes and obesity (6). Activation 
of the browning response in WAT may represent a process underlying this altered systemic 
energy balance; therefore, we assessed the effect of dietary nitrate on the expression of brown 
adipocyte-specific genes in WAT in vivo. Wistar rats were treated with 0.35 mM, 0.7 mM or 
1.4 mM NaNO3 in drinking water for 18 days based on preliminary dose escalation studies. 
Plasma nitrate concentrations were found to increase in a dose-dependent fashion, with the 
basal concentration in control rats at 11.1 ± 0.7 µM, increasing to 15.4 ± 2.0 µM, 22.8 ± 4.0 
µM, and 32.6 ± 5.0 µM in the rats treated with 0.35 mM, 0.7 mM and 1.4 mM NaNO3, 
respectively. Water and food intake was not significantly different between the groups (Table 
S1). Since it is the subcutaneous WAT that has the greatest predisposition to undergo 
browning and influence energy balance (23), we concentrated our analyses on the inguinal 
WAT depot. Nitrate dose-dependently increased brown adipocyte-specific gene expression in 
WAT. The expression of UCP-1 was increased, as was the molecular marker of brown-like 
adipocytes, cell death-inducing DFFA-like effector a (CIDEA), which has a role in the 
regulation of the thermogenic process (Fig. 1A). Expression of PGC-1α, and the 
mitochondrial electron transport chain component cytochrome c (CYCS) were increased 
dose-dependently. Nitrate also increased expression of β-oxidation genes including carnitine 
palmitoyltransferase 1 (CPT1) and acyl-CoA dehydrogenase, very long chain (ACADvl) 
(Control vs. 0.35 mM NaNO3 P ≤ 0.01, Control vs. 0.7 mM NaNO3 P ≤ 0.0001, Control vs. 
1.4 mM NaNO3 P ≤ 0.001). Specific beige-selective genes, including T-box transcription 
factor (Tbx1), Transmembrane Protein 26 (Tmem26) and CD137, distinguish beige fat cells 
from both classical brown and white adipocytes (29). Nitrate moderately increased the 
expression of the beige-selective markers Tbx1, Tmem26 and CD 137 specifically 
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 characterizing these cells as beige adipocytes within the inguinal WAT depot (Fig. S1). 
Nitrate did not significantly change the expression of the canonical adipocyte-specific 
markers adiponectin (ADIPOQ) and fatty acid binding protein 4 (FABP4) in the WAT 
indicating that adipose tissue exposed to nitrate presents similar levels of adipogenesis (Fig. 
S2). Furthermore, analysis of brown-adipocyte specific gene expression in the visceral 
(epididymal) WAT of nitrate treated rats also revealed a moderate increase in the mRNA of 
several genes involved in the thermogenic and browning process (Fig. S3). 
 
To determine whether changes in the expression of key brown adipocyte-specific genes were 
translated to the level of protein, the concentrations of UCP-1, PGC-1α and CPT1 protein in 
the subcutaneous WAT of nitrate treated rats were analyzed. Nitrate increased the expression 
of the brown-adipocyte specific proteins UCP-1 and PGC-1α (Control vs. 0.35 mM NaNO3 P 
≤ 0.001, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P = 0.01) (Fig 
1.B). Nitrate also increased the concentration of the β-oxidation protein CPT1 within WAT 
(Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 
mM NaNO3 P ≤ 0.05) (Fig. 1C). The observed induction of characteristic brown adipocyte 
genes and increase in the concentration of brown adipocyte-specific proteins suggests a 
browning of the subcutaneous WAT.  
 
We next examined whether the changes in gene and protein expression induced by nitrate 
resulted in altered energy metabolism within the WAT. The activity of citrate synthase, a 
marker of mitochondrial density and TCA cycle flux, was significantly increased following 
nitrate treatment, suggesting increased mitochondrial biogenesis consistent with browning of 
WAT (Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control 
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 vs. 1.4 mM P ≤ 0.01) (Fig. 1D). Since beige/brite cells utilize fatty acids as fuel for 
thermogenesis, we investigated whether nitrate affected lipid metabolism in the WAT of 
treated rats. GC-MS and LC-MS were utilized to measure total fatty acid and triacylglycerol 
(TAG) species in the WAT, respectively. Nitrate treatment increased the medium chain fatty 
acid (MCFA) (laurate, myristate) / long chain fatty acid (LCFA) (arachidate, behenate) ratio, 
indicative of increased β-oxidation shortening fatty acid chain length (Control vs. 0.35 mM 
NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P ≤ 0.01) 
(Fig. 1E and Fig. S4). LC-MS analysis demonstrated that nitrate also decreased the total TAG 
content within WAT (0.95-fold, 0.35 mM NaNO3; 0.94-fold, 0.7 mM NaNO3; 0.98-fold, 1.4 
mM NaNO3; Control vs. 0.35 mM P ≤ 0.01, Control vs. 0.7 mM P ≤ 0.01) (Fig. 1F). 
Therefore, metabolic changes induced in WAT in vivo by nitrate treatment were characteristic 
of a brown adipocyte-like phenotype. 
 
Histological analyses of the inguinal WAT of nitrate treated rats at fifty-times magnification 
revealed the presence of fascicles of multilocular brown adipocyte-like cells (Fig 1G). Under 
greater magnification the smaller multilocular brown adipocyte-like cells can be observed 
confirming morphological changes in the WAT. Together these data indicate that nitrate 
induces the browning of WAT.    
 
To ensure nitrate-induced expression of brown adipocyte-specific genes in rat WAT is not 
species-specific, mice were treated with 0.7 mM NaNO3 in drinking water. As in rat, brown 
adipocyte-specific gene expression was increased in inguinal WAT by nitrate treatment (Fig. 
S5A). The expression of thermogenic genes in classical iBAT from nitrate treated mice was 
also increased (Fig. S5B). 
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Nitrate Induces a Brown Adipocyte-like Phenotype in White Adipocytes In Vitro 
Nitrate may function directly to increase the expression of brown adipocyte-specific genes in 
WAT or indirectly through metabolic bioactivation in cells distinct from those in the target 
tissue. Therefore stromal vascular fraction-derived primary adipocytes isolated from inguinal 
WAT of mice were treated with nitrate. NaNO3 concentrations of 25 µM, 50 µM and 500 µM 
were chosen. The latter two concentrations correspond to plasma levels in mice exhibiting 
improved metabolic phenotypes when chronically treated and acutely dosed with 0.1 
mmol/kg of NaNO3, respectively (6). Nitrate treatment significantly increased the expression 
of brown-adipocyte specific genes UCP-1, CIDEA and PGC-1α. Also increased in expression 
were CYCS, CPT1 and ACADvl (Control vs. 25 µM NaNO3 P ≤ 0.01, Control vs. 50 µM 
NaNO3 P ≤ 0.0001, Control vs. 500 µM NaNO3 P ≤ 0.0001) (Fig. 2A). By contrast, nitrate did 
not significantly affect the expression of a panel of classical mature adipocyte-specific genes 
including ADIPOQ, FABP4, and adipsin, suggesting that nitrate dose not directly affect 
adipogenesis per se (Fig. S6) (29).  These data indicate nitrate mediated induction of brown-
adipocyte specific gene expression occurs directly at the WAT.    
We next investigated whether the transcriptional changes induced by nitrate conferred 
functional effects on energy expenditure in primary adipocytes. The O2 consumption rates of 
adipocytes treated with nitrate (50 µM and 500 µM) were measured (Fig. 2B). The basal O2 
consumption rate was dose-dependently increased in adipocytes treated with nitrate (Control 
3.1 nmoles O2/min/10
6
 cells, 50 µM NaNO3 4.5 nmoles O2/min/10
6
 cells, 500 µM NaNO3 5.1 
nmoles O2/min/10
6
 cells, P ≤ 0.05). Maximal respiratory rates were probed using excess 
succinate (20 mM) (27), and were found to increase in adipocytes treated with nitrate 
(Control 4.2 nmoles O2/min/10
6
 cells, 50 µM NaNO3 6.6 nmoles O2/min/10
6
 cells, 500 µM 
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 NaNO3 7.7 nmoles O2/min/10
6
 cells, P ≤ 0.05). These findings indicate that nitrate increases 
the respiration of adipocytes consistent with the browning response (Control vs. 50 µM 
NaNO3 P ≤ 0.01, Control vs. 500 µM NaNO3 P ≤ 0.001).   
GC-MS analysis of the fatty acid metabolism of adipocytes treated with nitrate also  
highlighted the increase in the MCFA/LCFA ratio, mirroring the effects observed in WAT in 
vivo (Control vs. 50 µM NaNO3 P ≤ 0.05, Control vs. 500 µM NaNO3 P = 0.08) (Fig. 2C). 
 
Nitrate Increases Fatty Acid Uptake and β-oxidation in White Adipocytes In Vitro 
To confirm the increased β-oxidation observed in nitrate treated adipocytes, the stable isotope 
substrate U-
13
C-palmitate was used to monitor flux through the fatty acid oxidation pathway. 
Primary adipocytes were incubated in serum-free media containing U-
13
C-palmitate and 
treated with nitrate. GC-MS analysis was used to determine the relative enrichment of 
metabolites. Nitrate significantly increased the 
13
C enrichment of palmitate (C16:0) in 
adipocytes, indicating increased fatty acid uptake (P ≤ 0.01) (Fig. 3A). Enrichment of shorter 
chain fatty acids, myristate (C14:0) and laurate (C12:0) was also increased in nitrate treated 
adipocytes (C14:0 P ≤ 0.05, C12:0 P ≤ 0.05) (Fig. 3B and 3C), consistent with augmented 
chain shortening through β-oxidation.  
 
The labeled fatty acids are catabolized releasing labeled acetyl-CoA which enters the TCA 
cycle. Nitrate treatment increased the labeling of TCA cycle intermediates, citrate (Control 
vs. 50 µM NaNO3 P ≤ 0.0001, Control vs. 500 µM NaNO3 P ≤ 0.001) (Fig. 3D), succinate 
(Control vs. 500 µM NaNO3 P ≤ 0.05) (Fig. 3E) and malate (Control vs. 500 µM NaNO3 P ≤ 
0.05) (Fig. 3F). Therefore, nitrate confers a functional effect on white adipocytes, increasing 
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 flux through fatty acid β-oxidation. Taken together, these data demonstrate that nitrate 
induces the expression of thermogenic genes and the development of a brown-fat like 
phenotype in white adipocytes and WAT.  
 
Nitrate Functions through the Nitrate-Nitrite-NO Pathway to Induce Browning of 
Adipocytes  
In addition to the classical L-arginine-nitric oxide synthase (NOS)-NO pathway, NO can also 
be generated in vivo from nitrate through serial reduction to nitrite and then to NO via the 
nitrate-nitrite-NO pathway (30). Therefore, we hypothesized that nitrate might be functioning 
via NO to produce the browning response in WAT. Primary adipocytes were differentiated in 
the presence of nitrate and the NO scavenger PTIO (Fig. 4A) (Control vs. 500 µM NaNO3 P ≤ 
0.0001, 500 µM NaNO3 vs. 500 µM NaNO3 + 50 µM PTIO P ≤ 0.0001). Sequestration of NO 
by PTIO negated the nitrate-induced expression of brown adipocyte-specific genes, 
indicating that nitrate indeed functions via NO to induce browning.  
To exclude the induction of NO production through the L-arginine-NOS-NO pathway as a 
mechanism of nitrate stimulated browning, control experiments were conducted using the 
non-isoform selective NOS inhibitor L-NAME. Inhibition of NOS did not affect nitrate-
stimulated brown adipocyte-specific gene expression in adipocytes (Fig. 4B) (Control vs. 500 
µM NaNO3 P ≤ 0.001, Control vs. 500 µM NaNO3 + 1mM L-NAME P ≤ 0.0001, 500 µM 
NaNO3 vs. 500 µM NaNO3 + 1mM L-NAME not significant). Therefore, nitrate stimulated 
browning functions through NO but independently of NOS.  
An enzymatic mechanism for the reduction of nitrate to NO in mammals, catalyzed by XOR, 
was recently reported (4). XOR is expressed in WAT and has a role in adipocyte homeostasis 
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 (31). Nitrate dose-dependently increased the expression of XOR in primary adipocytes (Fig. 
4C). Using PTIO, the nitrate stimulated increase in XOR expression was demonstrated to be 
mediated through NO (Fig. 4D). The expression of XOR in primary adipocytes was knocked 
down by approximately 80% using siRNA (Fig 4E). Knockdown of XOR abrogated the 
nitrate-induced expression of brown adipocyte-specific genes in white adipocytes (Fig 4F). 
Consistent with these results, nitrite promoted brown adipocyte-specific gene expression in 
adipocytes via an NO-dependent mechanism (Fig. S7A, B). By examining fold-increases of 
brown adipocyte-specific genes, nitrite at equivalent concentrations to nitrate appeared more 
potent in inducing the browning response, consistent with the inefficient overall rate of 
reduction of nitrate to nitrite and eventually NO (4). These results indicate that nitrate 
mediated browning of adipocytes requires XOR and the reduction of nitrate to NO.     
 
Nitrate Increases Browning of Adipocytes Through a cGMP and Protein Kinase G 
Mediated Mechanism  
We next characterized the downstream signaling/effector pathways mediating nitrate-induced 
browning of WAT. NO activates cGMP signaling through stimulation of soluble guanylyl 
cyclase (3). cGMP mediates browning of WAT (9) suggesting cGMP signaling as a potential 
mechanism underlying nitrate-induced browning.  Therefore, we measured the concentration 
of cGMP in nitrate treated adipocytes using LC-MS (Fig. 5A). Nitrate increased the 
concentration of cGMP in adipocytes, from 2.7 pmoles/10
6
 cells in the control to 5.2 
pmoles/10
6
 cells and 4.9 pmoles/10
6
 cells in the 50 µM NaNO3 and 500 µM NaNO3 treated 
cells, respectively (P = 0.04, Control vs. 50 µM NaNO3 P ≤ 0.05, Control vs. 500 µM NaNO3 
P ≤ 0.05) (Fig. 5B). Similarly, analysis of WAT from rats demonstrates an increase in cGMP 
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 concentrations in vivo, following  nitrate treatment (P < 0.05, Control vs. 0.35mM NaNO3 P ≤ 
0.01, Control vs. 0.7mM NaNO3 P ≤ 0.05, Control vs. 1.4mM NaNO3 P = 0.07) (Fig. 5C).  
The pharmacological inhibitor of guanylyl cyclase, ODQ, was used to confirm a cGMP-
dependent mechanism for nitrate-induced browning. Inhibition of guanylyl cyclase abolished 
the nitrate-induced expression of brown adipocyte-specific genes in white adipocytes 
(Control vs. 500 µM NaNO3 P ≤ 0.0001, 500 µM NaNO3 vs. 500 µM NaNO3 + 1 µM ODQ 
P ≤ 0.001) (Fig. 5D).  
The cGMP-dependent protein kinase G (PKG) is expressed in the WAT of rodents and is a 
key regulator of adipocyte function (9; 32). Using a pharmacological inhibitor of PKG 
(KT5823) we investigated the role of this protein kinase in the nitrate-induced browning 
response. Inhibition of PKG abrogated the nitrate-induced expression of brown-adipocyte 
specific genes in the adipocytes (Control vs. 500 µM NaNO3 P ≤ 0.0001, 500 µM NaNO3 vs. 
500 µM NaNO3 + 1 µM KT5823 P ≤ 0.0001) (Fig. 5E). Therefore, the mechanism 
underlying nitrate-induced browning of WAT functions through the cGMP/PKG signaling 
axis.   
 
Nitrate Induced Browning of WAT is Enhanced In Hypoxia  
Unlike the L-arginine-NOS-NO pathway, which is dependent on oxygen, production of NO 
through the nitrate-nitrite-NO pathway is augmented as oxygen concentrations decrease (33) 
and may regulate tissue adaptations to hypoxia (34; 35). Since the nitrate-induced browning 
of WAT is mediated through the nitrate-nitrite NO pathway, we examined the capacity of 
nitrate to increase brown adipocyte-specific gene expression in adipocytes during hypoxia.  
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 Primary adipocytes were treated with NaNO3 (50 µM) in low oxygen conditions (2% O2). 
These oxygen concentrations correspond to levels observed in obese WAT (36). In parallel, 
adipocytes from the same stromal vascular isolation were treated with NaNO3 (50 µM) under 
normoxic conditions. Since nitrate-induced browning requires the reduction of nitrate to NO, 
and XOR functions to reduce nitrate to NO (4), we assessed the expression of XOR in the 
adipocytes in response to changes in oxygen availability. XOR expression was found to 
increase in adipocytes exposed to hypoxia, an effect enhanced by simultaneous nitrate 
treatment (Fig. 6A) (Normoxia Control vs. Hypoxia Control P ≤ 0.01, Hypoxia Control vs. 
Hypoxia 50 µM NaNO3 P ≤ 0.05, Normoxia 50 µM NaNO3 vs. Hypoxia 50 µM NaNO3 P ≤ 
0.001). Nitrate also increased the expression of brown adipocyte-specific genes in both the 
normoxia and hypoxia conditioned cells (Normoxia Control vs. Normoxia 50 µM NaNO3 P ≤ 
0.0001, Hypoxia Control vs. Hypoxia 50 µM NaNO3 P ≤ 0.0001) (Fig. S8A). Hypoxia per se 
significantly decreased the expression of the brown-adipocyte specific genes compared to 
normoxia (Normoxia Control vs. Hypoxia Control P ≤ 0.01). However, nitrate increased the 
expression of the brown-adipocyte specific genes and fully restored the expression of UCP1, 
CIDEA and CPT1 under hypoxia to levels greater than that of normoxic controls. The 
decrease in expression of the genes due to hypoxia alone was corrected for by normalizing 
the hypoxia conditioned cells to hypoxia control to facilitate comparison of the fold-changes 
in expression of the browning genes following nitrate treatment (Fig. 6B). The fold-change 
increase of brown adipocyte-specific gene expression in hypoxic adipocytes treated with 
nitrate compared to hypoxic control was significantly greater than that observed in normoxic 
cells (Normoxia 50 µM NaNO3 vs. Hypoxia 50 µM NaNO3 P ≤ 0.0001). 
 
To investigate the enhanced browning effect of nitrate in WAT under hypoxic conditions in 
vivo, rats were housed in a hypoxia chamber and either received 0.7mM NaCl or 0.7 mM 
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 NaNO3 in their drinking water for 14 days. A parallel group of rats were identically treated 
but housed in a normoxic environment. Water and food intake was not significantly different 
between the groups (Table S2). As in vitro, XOR expression was increased in WAT of rats 
exposed to hypoxia, and further enhanced by nitrate treatment (Fig. 6C) (Normoxia Control 
vs. Hypoxia Control P ≤ 0.01, Normoxia 50 µM NaNO3 vs. Hypoxia 50 µM NaNO3 P ≤ 
0.01).  As expected, nitrate increased expression of brown adipose-specific genes in WAT 
during normoxia (Normoxia Control vs. Normoxia 0.7 mM NaNO3, P ≤ 0.01) (Fig. 6D). 
Brown adipocyte-specific gene expression was also increased in the WAT of rats treated with 
nitrate under hypoxic conditions (Hypoxia Control vs. Hypoxia 0.7 mM NaNO3, P < 0.0001). 
Interestingly, brown adipocyte-specific gene expression within WAT was significantly 
increased in the rats treated with nitrate during hypoxia when compared to those treated with 
nitrate and housed in a normoxic environment (Normoxia 0.7 mM NaNO3 vs. Hypoxia 
0.7mM NaNO3, P < 0.0001). The expression of ADIPOQ was not significantly affected by 
either nitrate or hypoxia (Fig. S8B). Overall, these data indicate that the nitrate-induced 
expression of brown adipocyte-specific genes in WAT is augmented in hypoxia. 
 
The WAT of obese humans and rodents is in a hypoxic state that perturbs metabolism, 
increasing glycolysis and de novo lipogenesis and decreasing fatty acid breakdown, further 
contributing to the pathology of obesity (36-39). Therefore, we investigated the effect of 
dietary nitrate on the expression of brown adipocyte-specific genes in WAT in a rodent 
model of obesity, the ob/ob mouse. Wild-type C57bl/6 and ob/ob mice received either 0.7 
mM NaCl or 0.7 mM NaNO3 in their drinking water for 8 weeks. Plasma nitrate 
concentrations were elevated from 59.8 µM ± 4 and 53.8 µM ± 11 in the chloride treated 
C57bl/6 and ob/ob mice respectively to 373.1 ± 73 and 323.9 ± 58 in their nitrate treated 
counterparts. The expression of several brown adipocyte-specific genes in the WAT of ob/ob 
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 mice was significantly reduced when compared to wild-type mice. Nitrate increased the 
expression of the brown adipocyte-specific genes, partially restoring the impaired levels of 
expression in this model of obesity (Fig 6E).  
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 Discussion 
Nitrate was considered a non-bioactive metabolite of NO and a potentially toxic dietary 
constituent. However, studies showing that nitrate reduces blood pressure (5; 7; 40) and the 
oxygen demand of exercise (41) indicated that this anion may be beneficial for metabolic 
health. Complementary studies demonstrated that nitrate has anti-obesity and anti-diabetic 
effects, independent of increased mitochondrial biogenesis or PGC1α expression in liver or 
muscle, in endothelial NOS-deficient mice, a strain prone to a metabolic syndrome-like 
phenotype (6). Similar anti-diabetic effects of nitrate have since been described in Sprague-
Dawley rats (42). Diets low in nitrate and nitrite reduce the concentration of cGMP in certain 
tissues (8). In recent years a role for cGMP signaling in systemic energy balance has emerged 
(32; 43; 44). cGMP was recently demonstrated to  induce browning within WAT (9). These 
beige/brite cells (14; 15) have cardiometabolic protective effects in rodents (11; 16; 18; 19; 
22; 23; 45). Thus, we hypothesized that nitrate might contribute to the improved metabolic 
phenotype by inducing the browning response in WAT. 
 
In the present study we demonstrate that nitrate increases the expression of thermogenic 
genes in BAT and activates a brown adipocyte-like transcriptional and functional phenotype 
within WAT. Furthermore, we find that nitrate induces browning of adipocytes through the 
NOS-independent nitrate-nitrite-NO pathway. Thus nitrate activates the thermogenic process 
in a manner distinct from physiological metabolite activators of browning previously 
described (Fig. S9) (20). Our findings suggest a mechanism by which nitrate is reduced to 
NO, which in turn increases cGMP production via soluble guanylyl cyclase activation. 
Increased cGMP concentrations activate PKG, increasing the expression of PGC-1α and 
other key browning genes such as UCP1 and CIDEA in white adipocytes. Increased 
expression of brown adipocyte-specific and β-oxidation pathway genes translates to a brown 
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 adipocyte-like functional phenotype characterized by increased fatty acid β-oxidation (Fig. 
7). Incidentally, the recently identified mechanism for natriuretic peptide induced browning 
of WAT was also revealed to signal through the cGMP cascade (43), underscoring the 
importance of this signaling pathway for the physiological activation of thermogenesis in 
WAT. 
 
It was observed that the nitrate-induced browning response in WAT was enhanced in 
hypoxia. The nitrate-nitrite-NO pathway is significantly augmented during hypoxia, with 
both the activity and expression of XOR increased in low oxygen conditions (4). The 
pathway has also been implicated in the adaptive response of some tissues to hypoxia (30; 33; 
35). It is conceivable that production of NO from nitrate leads to the enhanced nitrate-
induced browning of WAT observed in hypoxia. The WAT of obese humans, and genetic and 
dietary models of obesity in rodents, is in a hypoxic state (36; 37). Exposure of adipocytes to 
hypoxia leads to cellular metabolic reprogramming, consisting of increased glycolysis and 
fatty acid and TAG synthesis and decreased fatty acid catabolism, that contributes to the 
pathology of obesity (38; 39). The identification of an enhanced capacity for nitrate to induce 
the browning response of WAT in low oxygen conditions through NO, which will likely also 
contribute to improved vascular health in obese individuals where NO production is 
decreased (46), may represent a significant therapeutic opportunity to partly reverse this 
hypoxia mediated pathological state. Indeed, our studies show that the impaired expression of 
several brown adipocyte-specific genes in the WAT of the ob/ob mouse model of obesity is 
partially reversed by nitrate treatment. 
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 From a nutritional perspective, humans are exposed to nitrate as part of their daily diet, with 
green leafy vegetables representing a significant source of the anion. A high vegetable 
component to diets is consistently shown to have a protective role in the development of 
metabolic morbidity (47; 48). It has been suggested that the high nitrate content of vegetables 
is partly responsible for their association with cardiometabolic protection (30; 34). It is worth 
speculating that increasing the flux through the nitrate-nitrite-NO pathway may be one 
mechanism through which dietary vegetable consumption confers the associated metabolic 
protection. Given that the concentrations of nitrate utilized in our study are readily achievable 
through dietary vegetable consumption (6; 34), dietary nitrate may also function to activate 
cGMP signaling in human WAT. The possibility that this ubiquitous dietary constituent could 
induce browning of WAT in humans is tantalizing.  
 
It should be noted that the responses of WAT to nitrate were not universally dose-dependent. 
This observation may represent rapid tachyphylaxis and/or resistance to inorganic nitrate, a 
phenomenon well characterized in the clinical use of organic nitrates, in particular at high 
doses. Alternatively, cellular uptake of inorganic nitrate may become rate-limiting or 
saturated at high doses. The NO signaling pathway is also subject to counter regulation 
through a number of disparate mechanisms that include the action of phosphodiesterases 
(PDEs), which may influence the effect of nitrate in WAT (Fig S10). PDEs such as PDE5, 
control cGMP concentrations and therefore inhibit downstream effects such as protein kinase 
G stimulation. Indeed, inhibition of PDE5 is known to stimulate the browning of WAT (9).  
 
In summary, we identify nitrate as a novel non-β-adrenergic activator of the browning 
response in WAT and highlight this small anion as both a potential dietary mediator of 
protection from, and potential therapeutic modality for the treatment of, metabolic disease.   
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 Figure Legends 
Fig. 1. Dietary nitrate induces a brown adipocyte-like phenotype in white adipose tissue 
(WAT) in vivo. (A) Increased expression of brown-adipocyte specific genes in subcutaneous 
WAT of nitrate treated rats (Two-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.01, 
Control vs. 0.7 mM NaNO3 P ≤ 0.001, Control vs. 1.4 mM P ≤ 0.0001). (B) Increased 
concentration of brown-adipocyte specific proteins in subcutaneous WAT of nitrate treated 
rats determined by ELISA (Two-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.001, 
Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM P ≤ 0.01) (C) Increased 
concentration of carnitine palmitoyltransferase 1 (CPT1) protein in subcutaneous WAT of 
nitrate treated rats determined by immunoblotting (One-way ANOVA, Control vs. 0.35 mM 
NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P ≤ 0.05).  
(D) Increased citrate synthase activity in subcutaneous WAT of nitrate treated rats (One-way 
ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, 
Control vs. 1.4 mM P ≤ 0.01) (E) The medium chain fatty acid (MCFA) / long chain fatty 
acid (LCFA) ratio in WAT from nitrate treated rats (One-way ANOVA, Control vs. 0.35 mM 
NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3 P ≤ 0.01). 
(F) LC-MS analysis of total triacylglycerols (TAGs) from WAT indicates decreased total 
TAGs stored in the WAT of nitrate treated rats (One-way ANOVA, Control vs. 0.35 mM 
NaNO3 P ≤ 0.01, Control vs. 0.7 mM NaNO3 P ≤ 0.01). (G) Haematoxylin and eosin staining 
of inguinal WAT of control and nitrate treated rats. Cumulative data from a total of 6 
independent observations are shown. Data are represented as Mean ± SEM. * P ≤ 0.05, ** P 
≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001. 
Fig. 2. Nitrate stimulates expression of brown adipocyte-specific genes and induces an 
oxidative phenotype in primary white adipocytes. (A) The expression of brown adipocyte-
specific genes in primary white adipocytes treated with nitrate (25 µM NaNO3, 50 µM 
NaNO3 and 500 µM NaNO3) (Two-way ANOVA, Control vs. 25 µM NaNO3 P ≤ 0.01, 
Control vs. 50 µM NaNO3 P ≤ 0.0001, Control vs. 500 µM NaNO3 P ≤ 0.0001). (B) Basal 
and stimulated (succinate 20 mM) oxygen consumption was increased in white adipocytes 
treated with nitrate, normalized to 10
6
 cells (Two-way ANOVA, Control vs. 50 µM NaNO3 P 
≤ 0.01, Control vs. 500 µM NaNO3 P ≤ 0.001). (C) The medium chain fatty acid (MCFA) / 
long chain fatty acid (LCFA) ratio was increased in white adipocytes with nitrate treatment 
(ANOVA, Control vs. 50 µM NaNO3 P ≤ 0.05, Control vs. 500 µM NaNO3 P ≤ 0.05). 
Cumulative data from a total of 4 independent observations are shown. Data are represented 
as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P < 0.0001. 
Fig. 3 Fatty acid uptake and β-oxidation is increased in nitrate treated primary white 
adipocytes characteristic of the browning response. (A) 
13
C-enrichment of palmitate (C16:0) 
was significantly increased in nitrate treated adipocytes (One-way ANOVA, P ≤ 0.01). (B) 
13
C-enrichment of myristate (C14:0) was significantly increased in nitrate treated adipocytes 
(One-way ANOVA, P ≤ 0.05). (C) 
13
C-enrichment of laurate (C12:0) was significantly 
increased in nitrate treated adipocytes (One-way ANOVA, P ≤ 0.05).  (D) 
13
C-enrichment of 
citrate was significantly increased in nitrate treated adipocytes (Two-way ANOVA, P ≤ 
0.0001, Control vs. 50 µM NaNO3 P ≤ 0.0001, Control vs. 500 µM NaNO3 P ≤ 0.001) (E) 
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 13
C-enrichment of succinate was significantly increased in nitrate treated adipocytes (Two-
way ANOVA, P ≤ 0.05, Control vs. 500 µM NaNO3 P ≤ 0.05). (F) 
13
C-enrichment of malate 
was significantly increased in nitrate treated adipocytes (Two-way ANOVA, P ≤ 0.05, 
Control vs. 500 µM NaNO3 P ≤ 0.05). Red highlighting indicates increased enrichment. 
Cumulative data from a total of 4 independent observations are shown. Data are represented 
as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01,*** P ≤ 0.001, **** P < 0.0001. 
Fig. 4. Nitrate functions through the nitrate-nitrite-NO pathway to induce browning of white 
adipocytes. (A) Brown adipocyte-specific gene expression in primary adipocytes treated with 
the NO scavenger PTIO (50 µM) with and without 500 µM NaNO3 (Two-way ANOVA, 
Control vs. 500 µM NaNO3 P ≤ 0.0001, 500 µM NaNO3 vs. 500 µM NaNO3 + 50 µM PTIO P 
≤ 0.0001) (n = 3). (B) Brown adipocyte-specific gene expression in primary adipocytes 
treated with the NOS inhibitor L-NAME (1 mM) with and without 500 µM NaNO3 (Two-
way ANOVA, Control vs. 500 µM NaNO3 P ≤ 0.001, Control vs. 500 µM NaNO3 + 1 mM L-
NAME P ≤ 0.0001) (n = 3). (C) The expression of xanthine oxidoreductase (XOR) in primary 
white adipocytes treated with nitrate (25 µM, 50 µM, 500 µM) (One-way ANOVA, Control 
vs. 50 µM NaNO3 P ≤ 0.05, Control vs. 500 µM NaNO3 P ≤ 0.05) (n = 4). (D) XOR 
expression in primary adipocytes treated with the NO scavenger PTIO (50 µM) with and 
without 500 µM NaNO3 (One-way ANOVA, Control vs. 500 µM NaNO3 P ≤ 0.01, 500 µM 
NaNO3 vs. 500 µM NaNO3 + 50 µM PTIO P ≤ 0.01) (n = 3). (E) XOR expression in primary 
adipocytes treated with negative control siRNA or siRNA against XOR with and without 500 
µM NaNO3 (n = 3 / group) (One-way ANOVA, Control siRNA vs.Control siRNA + 500 µM 
NaNO3 P ≤ 0.001, Control siRNA vs XOR siRNA P ≤ 0.001, Control siRNA vs XOR 
siRNA+ 500 µM NaNO3 P ≤ 0.001) (F) Brown adipocyte-specific gene expression in primary 
adipocytes treated with negative control siRNA or siRNA against XOR with and without 500 
µM NaNO3 (n = 3 / group) (Two-way ANOVA, Control siRNA vs Control siRNA + 500 µM 
NaNO3 P ≤ 0.0001, Control siRNA + 500 µM NaNO3 vs XOR siRNA+ 500 µM NaNO3 P ≤ 
0.0001, XOR siRNA vs XOR siRNA+ 500 µM NaNO3 not significant).  Data are represented 
as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P < 0.0001. 
Fig. 5. cGMP signaling mediates the nitrate stimulated browning response in white 
adipocytes. (A) LC-MS chromatograms of typical peaks for cGMP from control and 500 µM 
NaNO3 treated primary adipocytes. (B) The concentration of cGMP increases in primary 
white adipocytes treated with nitrate (ANOVA, P ≤ 0.05, Control vs. 50 µM NaNO3 P ≤ 0.05, 
Control vs. 500 µM NaNO3 P ≤ 0.05) (n = 4). (C) The concentration of cGMP increases in 
white adipose tissue of rats treated with nitrate (0.35 mM NaNO3, 0.7 mM NaNO3 and 1.4 
mM NaNO3) (ANOVA, P < 0.05, Control vs. 0.35 mM NaNO3 P ≤ 0.01, Control vs. 0.7 mM 
NaNO3 P ≤ 0.05, Control vs. 1.4 mM NaNO3, P = 0.07) (n = 6). (D) Primary adipocytes 
treated with the guanylyl cyclase inhibitor ODQ (1 µM) with and without 500 µM NaNO3 
(Two-way ANOVA, Control vs. 500 µM NaNO3 P ≤ 0.0001, 500 µM NaNO3 vs. 500 µM 
NaNO3 + 1 µM ODQ P ≤ 0.001) (n = 6). (E) Primary adipocytes treated with the protein 
kinase G inhibitor KT5823 (1 µM) with and without 500 µM NaNO3 (Two-way ANOVA,  
Control vs. 500 µM NaNO3 P ≤ 0.0001, 500 µM NaNO3 vs. 500 µM NaNO3 + 1 µM KT5823 
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 P ≤ 0.0001) (n = 3). Data are represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, **** P < 
0.0001. 
Fig. 6. The nitrate stimulated browning response is enhanced in hypoxia. (A) Nitrate (50 µM 
NaNO3) induced expression of xanthine oxidoreductase (XOR) in white adipocytes is 
increased in hypoxia (Two-way ANOVA, Normoxia Control vs. Hypoxia Control P ≤ 0.01, 
Normoxia NaNO3 vs. Hypoxia NaNO3 P ≤ 0.001, Hypoxia Control vs. Hypoxia NaNO3 P ≤ 
0.05) (n = 4). (B)  The expression of brown adipocyte-specific genes in primary white 
adipocytes treated with nitrate (50 µM NaNO3) in normoxia or hypoxia and normalized to 
relevant control (normoxia 50 µM nitrate normalized to normoxia control, hypoxia 50 µM 
nitrate normalized to hypoxia control) (Two-way ANOVA, Normoxia NaNO3 vs. Hypoxia 
NaNO3 P ≤ 0.001) (n = 4). (C) The expression of XOR in white adipose tissue (WAT) of 
nitrate treated (0.7 mM NaNO3) rats is increased in hypoxia (Two-way ANOVA, Normoxia 
Control vs. Hypoxia Control P ≤ 0.01, Normoxia NaNO3 vs. Hypoxia NaNO3 P ≤ 0.01, 
Hypoxia Control vs. Hypoxia NaNO3 P ≤ 0.05) (n = 5). (D) The increased expression of 
brown-adipocyte specific genes in WAT of nitrate treated rats is enhanced during hypoxia 
(Two-way ANOVA, Normoxia 0.7 mM NaNO3 vs. Hypoxia 0.7mM NaNO3, P < 0.0001) (n 
= 5). (E) The reduced expression of brown adipocyte-specific genes in WAT of the ob/ob 
mouse compared to wild type controls is partially restored following nitrate treatment. (Two-
way ANOVA, Wild Type Control vs. ob/ob Control P ≤ 0.0001, Wild Type Control vs. Wild 
Type NaNO3 P ≤ 0.01, ob/ob Control vs. ob/ob NaNO3 P ≤ 0.0001)  Data are represented as 
Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P < 0.0001. 
 
Fig. 7.  Proposed mechanism for nitrate-induced browning of white adipocytes. After entering 
the cell, nitrate is reduced first to nitrite, then to nitric oxide (NO). NO increases cGMP 
production via soluble guanylyl cyclase activation. Increased cGMP concentrations activate 
PKG, increasing the expression of PGC-1α and key browning genes. Increased expression of 
brown adipocyte-specific and β-oxidation pathway genes confers an oxidative brown 
adipocyte-like functional phenotype on the white adipocytes. ACAD, acyl-CoA 
dehydrogenase; CIDEA, cell death-inducing DFFA-like effector a; cGMP, cyclic guanosine 
monophosphate; CPT1, carnitine palmitoyltransferase; CYCS, cytochrome c; GTP, 
Guanosine triphosphate; LCFA, long chain fatty acid; NO, nitric oxide; ODQ, 1H-[1,2,
4]oxadiazolo[4,3-a]quinoxalin-1-one; PGC1α, peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha; SCFA, short chain fatty acid; UCP1, uncoupling protein 1; XOR, 
xanthine oxidoreductase. 
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 Supplementary Text 
Nitrate Increases Browning of White Adipocytes Through a PPARα Independent Mechanism 
We have shown that nitrate increases the expression of PGC-1α in vivo and in vitro. PGC-1α 
drives the expression of brown adipocyte-specific genes in white adipocytes and regulates 
many of its effects through co-activation of transcription factors such as peroxisome 
proliferator-activated receptors (PPARs) (1). PPARα has been shown to mediate the effect of 
a number of activators of the browning response in white adipocytes (2-4). Therefore, we 
examined the effect of nitrate on brown adipocyte-specific gene expression in primary white 
adipocytes differentiated from the stromal vascular fraction of subcutaneous WAT of PPARα 
knockout mice. The absence of PPARα had no effect on the activity of nitrate to increase 
brown adipocyte-specific gene expression within the white adipocytes (Fig. S9). Nitrate 
treatment significantly increased the expression of UCP-1, CIDEA, PGC-1α, ELOVL3, 
CYCS and CPT1 (ANOVA, P < 0.0001, Control vs. 50 µM NaNO3 P ≤ 0.0001, Control vs. 
500 µM NaNO3 P ≤ 0.0001). Thus, nitrate activates the browning response in white 
adipocytes independently of PPARα. 
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 Supplementary Figures 
 
Fig. S1 The expression of beige adipocyte-specific markers Tbx1, Tmem26 and 
CD137 is increased in white adipose tissue of nitrate treated rats (0.35 mM NaNO3, 0.7 mM 
NaNO3, 1.4 mM NaNO3). Cumulative data from a total of 6 independent observations are 
shown. Data are represented as Mean ± SEM. * P ≤ 0.05 
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Fig. S2 The expression of both adiponectin (ADIPOQ) and fatty acid binding protein 
4 (FABP4) is not significantly different in white adipose tissue of nitrate treated rats (0.35 
mM NaNO3, 0.7 mM NaNO3, 1.4 mM NaNO3). Cumulative data from a total of 6 
independent observations are shown. Data are represented as Mean ± SEM.  
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Fig. S3 The expression of browning genes in epididymal white adipose tissue of rats 
treated with inorganic nitrate (0.7 mM) for 18 days. Exposure to nitrate significantly 
increased the expression of the brown adipocyte-specific genes UCP-1, CIDEA, PGC-1α and 
CYCS. Cumulative data from a total of 5 independent observations are shown. Data are 
represented as Mean ± SEM. ****, P ≤ 0.0001. 
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Fig. S4 The concentration of long chain and medium chain fatty acids measured by 
GC-MS in white adipose tissue of rats treated with inorganic nitrate (0.35 mM, 0.7 mM, 1.4 
mM). (A). Arachidate. (B) Behenate. (C) Laurate. (D) Myristate. Cumulative data from a total 
of 6 independent observations are shown. Data are represented as Mean ± SEM. *, P ≤ 0.05, 
**, P ≤ 0.01. 
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Fig. S5 (A) Brown adipocyte-specific gene expression in subcutaneous WAT of mice 
treated with 0.7 mM NaNO3 in drinking water for 15 days. (B) Real-time qPCR analysis 
shows increased expression of thermogenic genes in iBAT of nitrate treated mice. 
Cumulative data from a total of 7 independent observations are shown. Data are represented 
as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, *** P ≤ 0.001, **** P ≤ 0.0001. 
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Fig. S6 Real-time qPCR analysis shows unchanged expression of classical mature 
adipocyte-specific genes adiponectin (ADIPOQ), fatty acid binding protein 4 (FABP4) and 
adipsin in primary white adipocytes treated with nitrate (25 µM, 50 µM and 500 µM). 
Cumulative data from a total of 4 independent observations are shown. Data are represented 
as Mean ± SEM. 
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Fig. S7 (A) The expression of brown-adipocyte specific genes is increased in primary 
white adipocytes treated with NaNO2 (50 µM and 500 µM) (Two-way ANOVA, Control vs. 
50 µM NaNO2 P ≤ 0.0001, Control vs. 500 µM NaNO2 P ≤ 0.0001). Cumulative data from a 
total of 4 independent observations are shown.  (B) Primary adipocytes differentiated from 
the stromal vascular fraction treated with the NO scavenger PTIO (50 µM) with and without 
500 µM NaNO2 (Two-way ANOVA, Control vs. 500 µM NaNO2 P ≤ 0.0001, 500 µM 
NaNO2 vs. 500 µM NaNO2 + 50µM PTIO P ≤ 0.001). Cumulative data from a total of 3 
independent observations are shown. Data are represented as Mean ± SEM. ***, P ≤ 0.001, 
****, P ≤ 0.0001. 
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Fig. S8 (A) The expression of brown adipocyte-specific genes in primary white 
adipocytes treated with nitrate (50 µM NaNO3) in normoxic and hypoxic conditions (Two-
way ANOVA, Normoxia control vs. Normoxia NaNO3 P ≤ 0.0001, Hypoxia Control vs. 
Hypoxia NaNO3 P ≤ 0.0001, Normoxia Control vs. Hypoxia Control P ≤ 0.01) (n = 4). (B) 
Real-time qPCR analysis shows unchanged expression of adiponectin (ADIPOQ) in 
subcutaneous white adipose tissue of nitrate treated rats both in normoxia and hypoxia. 
Cumulative data from a total of 5 independent observations are shown. Data are represented 
as Mean ± SEM. **, P ≤ 0.01, ****, P ≤ 0.0001. 
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Fig. S9  Nitrate increases expression of brown adipocyte-specific genes in primary 
white adipocytes differentiated from the stromal vascular fraction isolated from inguinal 
WAT of PPARα null mice (Two-way ANOVA, Control vs. 50 µM NaNO3 P ≤ 0.0001, 
Control vs. 500 µM NaNO3 P ≤ 0.0001). Cumulative data from a total of 4 independent 
observations are shown. Data are represented as Mean ± SEM. ****, P ≤ 0.0001. 
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Fig. S10 Nitrate increases expression of phosphodiesterase 5 (PDE5) in white 
adipocytes in vivo and in vitro. (A) Increased expression of PDE5 in subcutaneous WAT of 
nitrate treated rats (One-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 
mM NaNO3 P ≤ 0.05, Control vs. 1.4 mM P ≤ 0.05). Six independent observations are 
shown. (B) The expression of PDE5 increased in primary white adipocytes treated with 
NaNO3 (25 µM, 50 µM and 500 µM) (One-way ANOVA, Control vs. 25 µM NaNO3 P ≤ 
0.05, Control vs. 50 µM NaNO3 P ≤ 0.05, Control vs. 500 µM NaNO3 P ≤ 0.001). Cumulative 
data from a total of 4 independent observations are shown. Data are represented as Mean ± 
SEM. * P ≤ 0.05, ***, P ≤ 0.001. 
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NaNO3 Dose  
Control 
(n=6) 
0.35 mM 
(n=6) 
0.7 mM 
(n=6) 
1.4 mM 
(n=6) 
 
Start weight (g) 
 
265 ± 5 268 ± 6 270 ± 4 271 ± 3 
 
End weight (g) 
 
406 ± 8 420 ± 13 415 ± 9 404 ± 4 
 
Food intake 
(g/day) 
30 ± 1 30 ± 1 30 ± 1 30 ± 1 
 
Water intake 
(mL/day) 
30 ± 3 35 ± 2 36 ± 3 32 ± 3 
 
Nitrate intake 
(mg/kg/day) 
1 ± 1 5 ± 2
 
8 ± 2 13 ± 1 
 
Table S1  Table of morphological parameters of rats treated with 0.35 mM, 0.7 mM and 
1.4 mM NaNO3 in drinking water for 18 days. Table detailing start and final weights, and 
food and water intakes, allowing subsequent calculation of daily nitrate intake.  
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  Normoxia 
0.7mM NaCl 
Normoxia 
0.7mM NaNO3 
Hypoxia 
0.7mM NaCl 
Hypoxia 
0.7mM NaNO3 
     
Start weight (g) 268 ± 5 268 ± 6 276 ± 2 280 ± 4 
End weight (g) 429 ± 8 431 ± 9 416 ± 14 412 ± 12 
Food Intake 
(g/day) 
 
 
32 ± 2 
 
33 ± 1 
 
35 ± 2 
 
33 ± 1 
Water Intake  
(ml/day) 
 
28 ± 1 28 ± 1 27 ± 4 32 ± 2 
Adipose tissue 
(g) 
3.5 ± 0.3 3.2 ± 0.2 4.4 ± 0.3 3.5 ± 0.3 
 
 
Tibia Length 
(mm) 
47 ± 0.2 47 ± 0.2 47 ± 0.4 47 ± 0.4 
 
Nitrate intake 
(mg/kg/day) 
1 ± 0 9 ± 0*** 1 ± 0 7 ± 0†††
aa 
 
Plasma 
Triglycerides 
(mmol / L) 
0.93 ± 0.2 1.317 ± 0.1†† 
aaa
 2.98 ± 0.4 *** 1.98 ± 0.2 *† 
 
Plasma Glucose 
(mmol/L) 
12.9 ± 1.5  15.3 ± 2.9 15.5 ± 0.4 12.4 ± 0.7 
 
Plasma Insulin 
(µg/L) 
2.7 ± 1 3.392 ± 1.2 1.410 ± 0.3 1.35 ± 0.4 
 
Table S2  Table detailing morphological parameters of rats treated with 0.7 mM NaCl 
or 0.7mM NaNO3 in drinking water and housed in normoxic or hypoxic conditions for 14 
days. Two-way ANOVA with Tukey’s post-hoc test, significant effect compared to 
normoxia/0.7 mM NaCl, * = p ≤ 0.05  ,** = p ≤ 0.01 ,*** = p ≤ 0.001. Two-way ANOVA 
with Tukey’s post-hoc test, significant effect compared to hypoxia/0.7 mM NaCl,  †† = p ≤ 
0.01 ,†††= p ≤ 0.001. 2-way ANOVA with Tukey’s post-hoc test, significant effect compared 
to normoxia/0.7mM NaNO3, aa = p ≤ 0.01, aaa = p ≤ 0.001. 
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Nitrate Increases Browning of White Adipocytes Through a PPARα Independent Mechanism 
 
We have shown that nitrate increases the expression of PGC-1α in vivo and in vitro. PGC-1α drives the 
expression of brown adipocyte-specific genes in white adipocytes and regulates many of its effects 
through co-activation of transcription factors such as peroxisome proliferator-activated receptors 
(PPARs) (1). PPARα has been shown to mediate the effect of a number of activators of the browning 
response in white adipocytes (2-4). Therefore, we examined the effect of nitrate on brown adipocyte-
specific gene expression in primary white adipocytes differentiated from the stromal vascular fraction of 
subcutaneous WAT of PPARα knockout mice. The absence of PPARα had no effect on the activity of 
nitrate to increase brown adipocyte-specific gene expression within the white adipocytes (Fig. S9). 
Nitrate treatment significantly increased the expression of UCP-1, CIDEA, PGC-1α, ELOVL3, CYCS 
and CPT1 (ANOVA, P < 0.0001, Control vs. 50 μM NaNO3 P ≤ 0.0001, Control vs. 500 μM NaNO3 P ≤ 
0.0001). Thus, nitrate activates the browning response in white adipocytes independently of PPARα. 
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Supplementary Figure 1. The expression of beige adipocyte-specific markers Tbx1, Tmem26 and 
CD137 is increased in white adipose tissue of nitrate treated rats (0.35 mM NaNO3, 0.7 mM NaNO3, 1.4 
mM NaNO3). Cumulative data from a total of 6 independent observations are shown. Data are 
represented as Mean ± SEM. * P ≤ 0.05 
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Supplementary Figure 2. The expression of both adiponectin (ADIPOQ) and fatty acid binding protein 
4 (FABP4) is not significantly different in white adipose tissue of nitrate treated rats (0.35 mM NaNO3, 
0.7 mM NaNO3, 1.4 mM NaNO3). Cumulative data from a total of 6 independent observations are 
shown. Data are represented as Mean ± SEM.  
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Supplementary Figure 3. The expression of browning genes in epididymal white adipose tissue of rats 
treated with inorganic nitrate (0.7 mM) for 18 days. Exposure to nitrate significantly increased the 
expression of the brown adipocyte-specific genes UCP-1, CIDEA, PGC-1α and CYCS. Cumulative data 
from a total of 5 independent observations are shown. Data are represented as Mean ± SEM. ****, P ≤ 
0.0001. 
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Supplementary Figure 4. The concentration of long chain and medium chain fatty acids measured by 
GC-MS in white adipose tissue of rats treated with inorganic nitrate (0.35 mM, 0.7 mM, 1.4 mM). (A). 
Arachidate. (B) Behenate. (C) Laurate. (D) Myristate. Cumulative data from a total of 6 independent 
observations are shown. Data are represented as Mean ± SEM. *, P ≤ 0.05, **, P ≤ 0.01. 
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Supplementary Figure 5. (A) Brown adipocyte-specific gene expression in subcutaneous WAT of mice 
treated with 0.7 mM NaNO3 in drinking water for 15 days. (B) Real-time qPCR analysis shows 
increased expression of thermogenic genes in iBAT of nitrate treated mice. Cumulative data from a total 
of 7 independent observations are shown. Data are represented as Mean ± SEM. * P ≤ 0.05, ** P ≤ 0.01, 
*** P ≤ 0.001, **** P ≤ 0.0001. 
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Supplementary Figure 6. Real-time qPCR analysis shows unchanged expression of classical mature 
adipocyte-specific genes adiponectin (ADIPOQ), fatty acid binding protein 4 (FABP4) and adipsin in 
primary white adipocytes treated with nitrate (25 μM, 50 μM and 500 μM). Cumulative data from a total 
of 4 independent observations are shown. Data are represented as Mean ± SEM. 
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Supplementary Figure 7. (A) The expression of brown-adipocyte specific genes is increased in primary 
white adipocytes treated with NaNO2 (50 μM and 500 μM) (Two-way ANOVA, Control vs. 50 μM 
NaNO2 P ≤ 0.0001, Control vs. 500 μM NaNO2 P ≤ 0.0001). Cumulative data from a total of 4 
independent observations are shown.  (B) Primary adipocytes differentiated from the stromal vascular 
fraction treated with the NO scavenger PTIO (50 μM) with and without 500 μM NaNO2 (Two-way 
ANOVA, Control vs. 500 μM NaNO2 P ≤ 0.0001, 500 μM NaNO2 vs. 500 μM NaNO2 + 50μM PTIO P 
≤ 0.001). Cumulative data from a total of 3 independent observations are shown. Data are represented as 
Mean ± SEM. ***, P ≤ 0.001, ****, P ≤ 0.0001. 
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Supplementary Figure 8. (A) The expression of brown adipocyte-specific genes in primary white 
adipocytes treated with nitrate (50 μM NaNO3) in normoxic and hypoxic conditions (Two-way 
ANOVA, Normoxia control vs. Normoxia NaNO3 P ≤ 0.0001, Hypoxia Control vs. Hypoxia NaNO3 P ≤ 
0.0001, Normoxia Control vs. Hypoxia Control P ≤ 0.01) (n = 4). (B) Real-time qPCR analysis shows 
unchanged expression of adiponectin (ADIPOQ) in subcutaneous white adipose tissue of nitrate treated 
rats both in normoxia and hypoxia. Cumulative data from a total of 5 independent observations are 
shown. Data are represented as Mean ± SEM. **, P ≤ 0.01, ****, P ≤ 0.0001. 
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Supplementary Figure 9. Nitrate increases expression of brown adipocyte-specific genes in primary 
white adipocytes differentiated from the stromal vascular fraction isolated from inguinal WAT of 
PPARα null mice (Two-way ANOVA, Control vs. 50 μM NaNO3 P ≤ 0.0001, Control vs. 500 μM 
NaNO3 P ≤ 0.0001). Cumulative data from a total of 4 independent observations are shown. Data are 
represented as Mean ± SEM. ****, P ≤ 0.0001. 
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Supplementary Figure 10. Nitrate increases expression of phosphodiesterase 5 (PDE5) in white 
adipocytes in vivo and in vitro. (A) Increased expression of PDE5 in subcutaneous WAT of nitrate 
treated rats (One-way ANOVA, Control vs. 0.35 mM NaNO3 P ≤ 0.05, Control vs. 0.7 mM NaNO3 P ≤ 
0.05, Control vs. 1.4 mM P ≤ 0.05). Six independent observations are shown. (B) The expression of 
PDE5 increased in primary white adipocytes treated with NaNO3 (25 μM, 50 μM and 500 μM) (One-
way ANOVA, Control vs. 25 μM NaNO3 P ≤ 0.05, Control vs. 50 μM NaNO3 P ≤ 0.05, Control vs. 500 
μM NaNO3 P ≤ 0.001). Cumulative data from a total of 4 independent observations are shown. Data are 
represented as Mean ± SEM. * P ≤ 0.05, ***, P ≤ 0.001. 
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Supplementary Table 1. Table of morphological parameters of rats treated with 0.35 mM, 0.7 mM and 
1.4 mM NaNO3 in drinking water for 18 days. Table detailing start and final weights, and food and 
water intakes, allowing subsequent calculation of daily nitrate intake. 
 
NaNO3 Dose  
Control 
(n=6) 
0.35 mM 
(n=6) 
0.7 mM 
(n=6) 
1.4 mM 
(n=6) 
 
Start weight (g) 
 
265 ± 5 268 ± 6 270 ± 4 271 ± 3 
 
End weight (g) 
 
406 ± 8 420 ± 13 415 ± 9 404 ± 4 
 
Food intake 
(g/day) 
30 ± 1 30 ± 1 30 ± 1 30 ± 1 
 
Water intake 
(mL/day) 
30 ± 3 35 ± 2 36 ± 3 32 ± 3 
 
Nitrate intake 
(mg/kg/day) 
1 ± 1 5 ± 2 8 ± 2 13 ± 1 
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Supplementary Table 2. Table detailing morphological parameters of rats treated with 0.7 mM NaCl or 
0.7mM NaNO3 in drinking water and housed in normoxic or hypoxic conditions for 14 days. Two-way 
ANOVA with Tukey’s post-hoc test, significant effect compared to normoxia/0.7 mM NaCl, * = p ≤ 
0.05  ,** = p ≤ 0.01 ,*** = p ≤ 0.001. Two-way ANOVA with Tukey’s post-hoc test, significant effect 
compared to hypoxia/0.7 mM NaCl,  †† = p ≤ 0.01 ,†††= p ≤ 0.001. 2-way ANOVA with Tukey’s post-
hoc test, significant effect compared to normoxia/0.7mM NaNO3, aa = p ≤ 0.01, aaa = p ≤ 0.001. 
 
 Normoxia 
0.7mM NaCl 
Normoxia 
0.7mM NaNO3 
Hypoxia 
0.7mM NaCl
Hypoxia 
0.7mM NaNO3 
     
Start weight (g) 268 ± 5 268 ± 6 276 ± 2 280 ± 4 
End weight (g) 429 ± 8 431 ± 9 416 ± 14 412 ± 12 
Food Intake 
(g/day) 
 
 
32 ± 2 
 
33 ± 1 
 
35 ± 2 
 
33 ± 1 
Water Intake  
(ml/day) 
 
28 ± 1 28 ± 1 27 ± 4 32 ± 2 
Adipose tissue 
(g) 
3.5 ± 0.3 3.2 ± 0.2 4.4 ± 0.3 3.5 ± 0.3 
 
 
Tibia Length 
(mm) 47 ± 0.2 47 ± 0.2 47 ± 0.4 47 ± 0.4 
 
Nitrate intake 
(mg/kg/day) 
1 ± 0 9 ± 0*** 1 ± 0 7 ± 0†††aa 
 
Plasma 
Triglycerides 
(mmol / L) 
0.93 ± 0.2 1.317 ± 0.1†† aaa 2.98 ± 0.4 *** 1.98 ± 0.2 *† 
 
Plasma Glucose 
(mmol/L) 
12.9 ± 1.5  15.3 ± 2.9 15.5 ± 0.4 12.4 ± 0.7 
 
Plasma Insulin 
(μg/L) 
2.7 ± 1 3.392 ± 1.2 1.410 ± 0.3 1.35 ± 0.4 
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